Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CFC-powered inhalers inclusion in FDA reform bill agreed to by Sen. Kennedy.

This article was originally published in The Tan Sheet

Executive Summary

CFC INHALER BILLS INCLUSION IN S 830 SUPPORTED BY SEN. KENNEDY as Senate and House conferees prepare to consider the FDA reform legislation. The Massachusetts Democrat is understood to be willing to accept the inclusion of Sen. Tim Hutchinson's (R-Ark.) S 1299, and its companion legislation in the House, Rep. Mark Foley's (R-Fla.) HR 2627, which would prevent FDA from banning metered-dose inhalers for asthma that use chlorofluorocarbon propellants until acceptable alternative products are available. Both measures would include OTC CFC inhalers in their purview ("The Tan Sheet" Oct. 27, p. 12).
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087716

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel